Stocks and Investing
Stocks and Investing
Thu, January 23, 2020
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, January 22, 2020
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jacob Hughes Maintained (TEVA) at Hold with Increased Target to $10 on, Jan 22nd, 2020
Jacob Hughes of Wells Fargo, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Increased Target from $8 to $10 on, Jan 22nd, 2020.
Jacob has made no other calls on TEVA in the last 4 months.
There are 2 other peers that have a rating on TEVA. Out of the 2 peers that are also analyzing TEVA, all agree with Jacob's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Chris Schott of "JP Morgan" Upgraded from Sell to Hold on, Tuesday, November 12th, 2019
- David Amsellem of "Piper Sandler" Maintained at Hold with Increased Target to $7 on, Friday, November 8th, 2019
Contributing Sources